Human Diseases - PowerPoint PPT Presentation

1 / 68
About This Presentation
Title:

Human Diseases

Description:

Human Diseases Caused Primarily by Gram-Positive and Gram-Negative Bacteria: The Airborne Diseases Part II Streptococci General features Cause variety of serious ... – PowerPoint PPT presentation

Number of Views:695
Avg rating:3.0/5.0
Slides: 69
Provided by: pagesCabr
Category:
Tags: diseases | human

less

Transcript and Presenter's Notes

Title: Human Diseases


1
  • Human Diseases
  • Caused Primarily by Gram-Positive and
    Gram-Negative Bacteria  
  • The Airborne Diseases Part II

2
Streptococci
3
  • General features
  • Cause variety of serious infections often leading
    to sequelae
  • Secondary complications arising during
    convalescent stage of infection
  • AKA nonsuppurative disease (inflammation in an
    organ that was NOT infected by the streptococcus)
  • Cocci spherical form pairs or chains during
    cell division
  • Nonmotile ? no flagellae

4
  • Fastidious
  • Require enriched medium for growth
  • Amino acis
  • Purines or pyrimidines
  • B vitamins
  • Laboratory culture
  • Complex, undefined medium
  • Peptones, glucose, salts, meat infusions and 5
    defibrinated blood agar (blood agar plates)

5
  • Most streptococci aerotolerant anaerobes
  • Some obligately anaerobic (female genital
    tract)
  • Sugar is fermented to lactic acid under aerobic
    and anaerobic conditions (homolactic acid
    fermenters)
  • Aerobic respiration is not possible
  • Lack the capability to syntesize heme (prosthetic
    group of cytochromes)
  • No electron transport using oxygen as TEA

6
  • Lack catalase
  • Therefore hydrogen peroxide can increase to toxic
    levels when grown aerobically
  • Blood agar minimizes this effect RBC provide
    catalase source
  • Hemolysins
  • Toxin secreted by streptococcus that results in
    lysis of RBC
  • Useful in determining streptococcal species
  • Alpha, beta or gamma hemolysis

7
  • Alpha hemolysis
  • Incomplete brown/green halo around CFU
  • Not lysed
  • Reduced product of hemoglobin
  • Examples
  • Viridans streptococci
  • S. parasanguis
  • S. mutans
  • S. pneumoniae
  • Some Group D streptococci (Enterococci and
    non-enterococci)
  • Both can cause UTI and subacute bacterial
    endocarditis

8
  • Beta hemolysis
  • Complete hemolysis
  • Clear zone around CFU
  • RBC are completely lysed
  • Streptolysin S (serum extractable and stable in
    air)
  • Streptolysin O (oxygen sensitive)
  • Anaerobic conditions needed to see effect
    mediated by this toxin
  • Examples
  • S. pyogenes
  • S. agalactiae

9
  • Gamma hemolysis
  • No hemolysis at all
  • Group N streptococci
  • Lactic streptococci
  • Some Enterococci Group D
  • 45oC, 6.5 NaCl, pH 9.6!!!!!!!

10
  • Classification
  • Biochemical and antigenic properties used to
    divide streptococci into different groups and
    subtypes
  • Rebecca Lancefield developed a Group
    Classification scheme

11
  • Used for all streptococci except the viridans
    group and S. pneumoniae based on a soluble
    carbohydrate antigenic (C carbohydrate) present
    in the cell wall ? Letter Code (A ? O no I or J)
  • C carbohydrate extractable with formamide or acid
    treatment with heating
  • All streptococci except viridans posses the C
    carbohydrate (even S. pneumoniae but not used in
    Lancefield groupsing)
  • Groups of streptococci based on Lancefields
    system can be linked to particular habitats

12
  • Species within groups (A?O) can be further
    subdivided into specific types based on other
    antigenic properties
  • Examples
  • A second cell wall protein called M protein is
    present on some Group A streptococci but no all
    members (60 different types!) ? Confer type
    specific immunity
  • Carbohydrates other than C carbohydrate

13
  • Group A beta-hemolytic streptococci
  • S. pyogenes
  • General features and virulence characteristics
  • Majority of streptococci responsible for acute
    infections belong to Group A
  • Associated with sequelae complications
  • Erythema nodosum skin
  • Rheumatic fever heat and joints
  • Acute glomerulonephritis kidney
  • 60 different subtypes based on M protein
    differences

14
  • Virulence factors
  • M protein virulence factor
  • Fimbriae of M protein stick out of the capsule
  • Antiphagocytic
  • Blocks alternate pathway of C activation
  • No C3b made ? therefore no opsonization
  • Superantigen characteristics
  • Stimulates T cells without processing requirements

15
  • Generates type-specific immunity
  • Only antibodies specific for particular M protein
    can bind and mediate opsonization
  • Capsule made of hyaluronic acid (present in
    connective tissue, therefore we are tolerant)

16
  • Adhesins
  • Enagle streptococci to bind to host cell
    glycoproteins
  • Streptococcal F protein
  • Lipoteichoic acid
  • Both bind fibronectin of ECM
  • Streptokinase
  • Secreted ? induces fibrinolysis which enhznces
    dissemination and prevents formation of fibrin
    barier
  • Connective tissue and basement membranes
    hydrolyzed

17
  • Hyaluronidase
  • Spreading factor
  • Made only if capsule is absent (capsule is made
    of hyaluronic acid)
  • Hosts hyaluronic acid degraded
  • Intercellular spaces opened
  • Dissemination

18
  • Streptodornase
  • DNAses 4x
  • Decrease viscosity in areas of cell lysis
  • Promote dissemination
  • Antibodies made during infection important in
    diagnosis

19
  • Streptolysin O (oxygen sensitive)
  • Binds to cholesterol and other sterols of host
    cell membrane
  • Toxin oligomers generated
  • Transmembrane pores formed
  • Cytotoxicity results
  • Lysosomal enzymes released into host cells
    cytosol degranulation)
  • Binds circulating IgG
  • Immune complexes formed
  • Complement activated
  • Tissue damage

20
  • Inhibits recruitment of leukocytes (suppresses
    chemotaxis)
  • Anti-streptolysin O antibody titers can assist n
    diagnosis of sequelae (Rheumatic fever and acute
    glomerulonehritis)

21
  • Streptolysin S
  • Only 28 amino acids
  • Oxygen stable
  • Inhibits chemotaxis and phagocytosis
  • Beta hemolysis of RBC and kills leukocytes
  • Not antigenic (too small??)
  • C5a peptidase
  • Removes 6 amino acids from COOH end of C5a
  • Interferes with binding to PML C receptors for
    C5a
  • Inhibits chemotaxis

22
  • Pyrogenic exotoxins A, B (aka Spe A,B) three
    serotypes
  • SpeA superantigen (Sag)
  • T cell cytokines damage blood vessls
  • Fluid loss
  • Tissue damage
  • Induce macrophage to syntesize TNF-alpha Il-1
  • Serotype A associated wiith scarlet fever and
    rheumatic fever

23
  • SpeB Exotoxin B
  • Cysteine protease
  • Destroys tissue rapidly
  • Associated with necrotizing fasciitis (flesh
    eating bacteria)
  • Erythrogenic toxins rash
  • Leukocidins leukocyte degranulation and death

24
  • Pathogenicity of Group A streptococci
  • Streptococcal pharyngitis STREP THROAT
  • Most common disease cause by these bacteria
  • Acute
  • Tonsils and pharynx inflamed (edematous
    fluid-filled)
  • Inflammatory response with lysis of erythrocytes
    and leucocytes
  • Enlarged cervical lymph nodes
  • Fever
  • Lasts only 5 days (self limiting)
  • Host makes antibodies to M protein

25
  • May spread to middle ear or meninges (rare)
  • Can cause pneumonia if present during a viral RTI
    (influenza or measles)
  • Spread through respiratory tract secretions from
    infected people or by contaminated food source
    (infected food handler lesions on hands)
  • Treatment is with penicillin, primarily to
    minimize the possibility of subsequent rheumatic
    fever and glomerulonephritis

26
  • Scarlet fever (Scarlatina)
  • Caused by erythrogenic toxin-positive Group A
    streptococci ( pyrogenic exotoxin A, SpeA SAg)
  • Caused by a lysogenic bacteriophage
  • Usually begins as sore throat, then toxin
    disseminates ? diffuse rash (if hypersensitivity
    reaction ensues or in absence of neutralizing
    antibodies)
  • Inasion of bacteria into the bloodstream
  • Fever
  • Strawberry-colored tongue

27
  • Skin shedding
  • Immunosuppression (due to effects of Sag)
  • Prevalent in mid 1800s, reemergence on the rise
  • If invasive, can trigger a streptococall toxic
    shock-like syndrome )TSLS)
  • Muppeteer Jim Hensen died of pneumonia produced
    by streptococcal infection
  • Decreased BP
  • Organ failure
  • Very high fever
  • Mortaity rategt30

28
  • Necrotizing fasciitis flesh eating bacteria
  • Infection of planes of tissue under the skin,
    especially in the fascia
  • Necrosis of skin owing ot destruction of blood
    vessels and nerve cells
  • Rapid spread, 50-80 mortality rate
  • Amputation often necessary
  • Tissue must be removed down to the muscle layer

29
  • Non-respiratory infections caused by Group A
    streptococcus
  • Streptococcal impetigo (pyoderma)
  • Superficial skin infection characterized by
    formation of small vesicles that develop into an
    amber crust
  • Often nephritogenic (affects kidneys) ? resulting
    in acute glomerulonephritis
  • Low socioeconomic environments
  • Crowded housing conditions
  • Superficial cutaneous infection commonly seen in
    children

30
  • Puerperal sepsis
  • Postpartum (following delivery of baby) uterine
    infection
  • Wound infections
  • Erysipelas acute infection of dermis, reddish
    patches
  • Often in combination with anotehr aobligate
    anaerobe of normal flora of gastrointestinal and
    genitourinary tracts (e.g. bacteroids)

31
  • Cellulitis
  • Diffuse, spreading infection of subcutaneous
    tissue characterized by redness and swelling

32
  • Diagnosis of Group A Streptococci
  • Tentative identification if beta hemolytic growht
    on blood agar plate (24 hours, 37oC)from throat
    swab
  • Gram positive cocci chains
  • Colonies small, dense/compact and dull

33
  • Specific serological identification
  • Latex bead agglutination
  • Anti-group A carbohydrate antibody bound to beads
  • Carbohydrate must first be extracted froom
    loopful of culture (from cfu or pharyngeal throat
    swab)
  • Positive agglutination confirms Group A
    streptococci
  • Bacitracin discs
  • Used to differentiate between Group A and Group B
    streptococci
  • Both beta hemolytic
  • Group A streptococci are sensitive (bacitracin
    sensitivity)

34
  • Fluorescence labeled antibodies specific for C
    carbohydrate
  • Non-suppurative sequelae complications
  • Immunological tests
  • High titer of anti-streptolysin O antibody
  • High titer of anti-streptodornase antibody
  • Suggestive of recent beta hemolytic strep
    infection

35
  • Late nonsuppurative sequelae complications of
    Group A Strep infections Immunological
    Aftermath Caused by Cross-Reactivity
  • Poststreptococcal diseases - onset is one to four
    weeks after an acute streptococcal infection
  • Erythema nodosum
  • Skin lesions following some Group A strep
    infections
  • Toxic agent???? Streptococcul cell wall???

36
  • Rheumatic fever
  • Heart and joints
  • Joints are unaffected after recovery but
    permanent heart damage can occur
  • Cross reactivity between myocarial and
    streptococcal components (M protein)
  • M protein deposition in heart and joints
  • Cross reactive antigen of streptococcus and heart
    tissue
  • Host antibodies can bind to self itssue
  • Immune complexes, complement activation, C5a,C3a,
    tissue damage and inflammation

37
  • Superantigen effect of M protein
  • Production of streptococcal cardiotoxin
  • Recent resurgence of actue rheumatic fever cases
  • Still very prevalent in developing nations
  • 25-40 of cardiovascular disease linked to RF
  • Involves the heart valves, other parts of the
    heart joints, subcutaneous tissues and central
    nervous system
  • Occurs primarily in children ages 6 to 15 years
    old
  • Therapy is directed at decreasing inflammation
    and fever, as well as controlling cardiac
    symptoms and damage

38
  • Acute glomerulonephritis
  • Less frequent than Rheumatic fever
  • Nephrotoxic action of streptococcal toxins
  • Cross reactivity with streptococcal antigens in
    glomeruli
  • Cross react with glomerular basement membranes of
    the kidney (?)
  • Immune complexes, complement activation, C3a,C5a,
    inflammation and tissue destruction
  • Bloody urine
  • Hypertension
  • Brights disease
  • May spontaneously heal or may become chronic
  • Possibly a kidney transplant or lifelong renal
    dialysis may eventually be necessary
  • A type III hypersensitivity

39
  • Treatment and prevention
  • Penicillin 8-10 days (cidal)
  • Rhematic fever prevented but not always acute
    glomerulonephritis
  • Erythromycin for penicillin-allergic patients
  • Prevention of re-infection important in those who
    have had Rheumatic fever (low dose penicillin
    daily for many years)
  • Carriers 5010 (up to 30 depending on season)
  • Therefore difficult t control spread of these
    bacteria

40
Streptococcus pneumoniae
41
  • General features
  • Pneumococcus
  • Alpha-hemolytic
  • Lancet-shaped pairs or short chains
  • Gram positive, nonmotile, non-spore forming
  • Encapsulated forms virulent
  • Primary virulence factor Multiplies quickly in
    alveolar spaces

42
  • Choline required growth factor (used as part of
    teichoic acid)
  • Lack cytochromes and catalase
  • Require complex, enriched growth medium
  • Part of normal flora
  • Nasopharynx
  • Therefore considered an endogenous infection
    (opportunist)
  • From here the pneumococcus can enter the blood
    stream

43
  • Associated with predisposing factors
  • Diabetes
  • Alcoholism
  • Viral infection of URT
  • Injury to respiratory tract

44
  • Classification
  • Polysaccharide capsule ? 80 different antigenic
    types (serological types)
  • C carbohydrate type specific M protein (but
    this M protein is not antiphagocytic)
  • Does not fit into the Lancefield scheme
  • Three common infections
  • Pneumonia
  • Meningitis
  • Otitis media

45
  • Pneumonia
  • Secreted pneumolysin believed to play a role in
    inhibiting antimicrobial properties of
    neutrophils and opsonization
  • Binds to cholesterol of host cells
  • Cytotoxic for pulmonary endothelial cells
  • May be partly responsible for alveolar
    hemorrhages (blood in sputum)
  • Capsule
  • Protects against phagocytosis virulence factor

46
  • Infections most common in conjunction with viral
    URT infection and in unhealthy or older patients
    (bedridden)
  • Smokers
  • People who have inhaled toxic irritants of URt
  • Acute lung inflammation
  • If it involves one or more lobes of the lungs
    lobar pneumonia
  • Or causes bronochopneumonia in children or
    elderly (more restricted than lobar pneumonia)
  • Exudate fills the alveoli ? compromising gas
    exchange and oxygen levels in the blood

47
  • Abrupt onset of chills, fever, pleural pain
  • Secondary complications
  • Can invade the sinuses (3-4-5 of bacterial
    cases), the middle ear and the meninges
  • Septicemia, endocarditis (inflammation of heart
    and valves), pericarditis (inflammation of
    membrane around the heart) and empyema (pleural
    cavity infection)
  • Anti-capsular antibodies lead to fast recovery

48
  • Meningitis
  • Second most common cause in adults
  • Occurs as complication of pneumonia or sinusitis
    ? dissemination into bloodstream
  • Can arise following skull fractures when they
    enter the meninges from the nasopharynx

49
  • Otitis media (middle ear infection)
  • About ½ of childhood cases of middle ear
    infections due to S. pneumonia
  • Only certain types responsible (6,14,19,24)

50
  • Diagnosis
  • Stain smears of sputum, CSF, blood or cultured
    sample
  • Gram positive, encapsulated diplococci or chains
  • Bile soluble
  • Quellung test
  • Capsule specific antibodies capsule swells
  • Replaced by more modern reagent omni-anti-serum
    (antibodies to all types of capsular antigens)
  • Optochin sensitivity discs (ethyl hydrocuprine
    hydrochloride)
  • Inhibitory to S. pneumoniae alpha hemolytic
  • Viridan streptococci grows also alpha hemolytic

51
  • Treatment and prevention
  • Penicillin G, or if sensitive/allergic to
    penicillin G, use cefotaxime, cephalothin or
    erythromycin for pneumonia
  • Chloramphenical for meningitis (BBB)
  • Vancomycin for penicillin resistant strains

52
  • Vaccines
  • Pneumovax
  • 23 types of capsular polysaccharides
  • Suggested for use in
  • Splenic disorders/splenectomy
  • Sickle cell anemia
  • Congestive heart failure
  • Diabetes mellitus
  • Alcoholism
  • The elderly in rest homes
  • Young children respond poorly (poor T-independent
    B cells responses)

53
Mycobacterium tuberculosis
54
  • Tuberculosis caused by tubercle bacillus
  • Extreme variation in the severity of disease
  • Mild
  • Chronic
  • Destruction of pulmonary tissue
  • Global health problem
  • Estimated 1 x 109 infected (20 of worlds
    population)
  • 107 new cases/year
  • 3 x 106 deaths/year
  • In USA 26,000 new cases/year with 12,000
    deaths/year, associated with AIDS epidemic

55
  • General features
  • Thin rods, straight or sometimes bent or club
    shaped
  • Non-motile, nonsporing, nonencapsulated,
    waxy-acid fast (Ziehl-Neelsen stain using carbol
    fuchsin)
  • Beaded or granular intracellular staining
  • High lipid and wax content mycolic acid
  • Mycolic acids isolated from Mycobacterium have
    60-90 carbon atoms
  • Rhodamine/auramine flluorochrome mix binds
    mycolic acid (fatty acids)

56
  • Obligate aerobes
  • Resistant to drying (sputum in bed linen)
  • Simple media requirements, but very slow growing
    (20 hours/division)
  • Killed by pasteurization
  • Cord factor (trehalose dimycolate)
  • Complex fatty acid associated with carbohydrate
  • Only found in virulent strains
  • Serpentine cords of growth result ? clumps
  • Induces TNF alpha (cachectin)

57
  • Pathogenicity
  • Spread by respiratory droplets and droplet nuclei
  • Can remain suspended in air for long periods
  • Highly infectious

58
  • Primary infection
  • Colonization of LRT ? small lesions primary
    complex ? can form tubercles
  • Tubercles tiny, hard nodules caused by a
    hypersensitivity response (DTH type IV)
  • Granuloma surrounded by fibrous tissue
  • Spread to draining lymph nodes
  • If tubercle lesion expands ? tissue is damaged
    a cheesy consistency referred to a caseation
    necrosis (caseous lesion)
  • After healing calcium deposits and cavities
    develop in the lungs
  • Ghon complexes calcified lesions seen in X-rays

59
  • If pulmonary vein involved in lesion then the
    bloodstream in invaded
  • Lesions develop elsewhere in other organs leading
    to Miliary tuberculosis (tubercles the size of
    millet seeds)

60
  • Can also lead to meningitis
  • Exudative lesions form early in primary infection
  • PMNLs, inflammation, fluid (exudate)
  • Dividing within macrophages until TH1 activated

61
  • Productive lesions (tubercles) form later on
  • Granulomatous lesions
  • Giant cells containing tubercle bacilli
    surrounded by a zone of epithelioid cells
  • Released to extracellular fluid
  • Walled off in the lung
  • Contain viable bacteria
  • Can survive indefinitely

62
  • Reactivation infection
  • Arise from walled-off tubercles (hence, not a
    primary infection)
  • Infection arises from latency
  • These patients would skin test positive

63
  • Immunity
  • TH1 recognize mycobacterial antigens with MHC
    class II on macrophage surface
  • Macrophages are activated by TH1 ? degradation of
    intracellular bacteria in lysosomal compartments
  • Once sensitized, a DTH response if exposed
    intradermally to M. tuberculosis antigens (PPD)
    (tuberculin skin test Heath test, Mantoux test,
    Tine test)
  • Often bacteria remain alive due to resistance to
    oxidative killing by macrophages

64
  • Clinical management (no more sanitariums)
  • Two drugs used in combination owing to drug
    resistance
  • Primary drugs
  • Isoniazid (INH) Rifampin, least toxic, most
    effective, 9 months
  • Long treatment required because
  • Mycobacteria grow slowly
  • Mycobacteria metabolize slowly
  • Drug doesnt easily penetrate the fibrotic or
    caseousl lesions
  • Secondary drugs
  • Pyrazinamide
  • Ethanbutol
  • Streptomycin
  • Three-in-one pill
  • INH, rifampin and pyrazinamide (approved by FDA
    in 1994)

65
  • Multidrug resistant M. tuberculosis (MDR-TB)
  • Resistant to INH and rifampin
  • Requirements for more drugs in cocktail (4 or 5
    total)
  • High mortality rates
  • Noncompliance of drug therapy thought to be
    responsible

66
  • Control
  • gt20,000 new cases annually in USA, 2500 deaths
  • Tuberculin skin test used for early detection
  • Indication of whether disease is quiescent or
    active (TDTH response)
  • Potential candidates for active disease
  • Those in close association with individual
    diagnosed with T.B. (prophylaxis)
  • Positive skin test and positive chest X-ray
  • Skin tested positive within 2 year period
  • Skin tested positive and immunocompromised
  • Silicosis, diabetes, transplant patients,
    leukemia, Hodgkins disease
  • lt35 years old and skin tested positive

67
  • Vaccine
  • BCG Bacille Calmette-Guerin (50 protection)
    (bovine strain)
  • Vole bacillus (murine strain)
  • Not used in USA because of diagnostic value of
    skin test as indicator of recent infection

68
  • Diagnosis
  • Samples of sputum, urine or gastric washings
    should be stained acid fast stain
  • Must also be cultured (several weeks)
  • Culture media
  • Selective for M.tb oleic acid, albumin,
    penicillin and dyes (malachite green)
  • ELISA and PCR hastens I.D.
  • Ghon complexes seen on X-ray
  • BACTEC and NPT test
Write a Comment
User Comments (0)
About PowerShow.com